Watchlist Price Alert

CSPC Pharmaceutical Group... (CSPCY)

OTC: CSPCY · Real-Time Price · USD

4.38

-0.16 (-3.42%)

At close: Jun 16, 2025, 3:29 PM

CSPC Pharmaceutical Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	29.01B	34.6B	31.59B	33.59B	28.03B	25.06B	18.47B	12.92B	11.08B
Cost of Revenue	8.71B	10.2B	8.86B	8.11B	7.03B	7.02B	6.25B	5.11B	5.43B
Gross Profit	20.3B	24.4B	22.73B	25.47B	21B	18.04B	12.22B	7.81B	5.65B
Operating Income	5.37B	7.68B	6.93B	7.53B	6.11B	5.05B	4.05B	2.89B	2.39B
Interest Income	n/a	n/a	247.65M	220.84M	115.54M	73.41M	n/a	25.15M	13.01M
Pretax Income	5.58B	7.39B	7.76B	8.23B	7.17B	5.18B	3.95B	2.9B	2.36B
Net Income	4.33B	5.87B	5.35B	5.61B	5.16B	4.21B	3.21B	2.32B	1.88B
Selling & General & Admin	9.74B	11.43B	11.72B	13.81B	11.64B	10.73B	7.12B	4.23B	2.99B
Research & Development	5.19B	5.34B	4.07B	4.14B	3.25B	2.27B	1.39B	815.26M	403.14M
Other Expenses	n/a	n/a	715.52M	545.69M	n/a	n/a	181.19M	n/a	284.26M
Operating Expenses	14.93B	16.72B	15.8B	17.95B	14.89B	13B	8.23B	4.9B	3.28B
Interest Expense	43.67M	25.9M	25.42M	9.24M	13.75M	36.77M	76.9M	22.25M	37.35M
Selling & Marketing Expenses	8.66B	9.14B	9.08B	10.44B	9.38B	n/a	6.44B	n/a	2.5B
Cost & Expenses	23.64B	26.92B	24.66B	26.06B	21.92B	20.02B	14.48B	10.01B	8.7B
Income Tax Expense	1.24B	1.32B	1.38B	1.4B	1.31B	1.01B	766.71M	572.6M	467.5M
Shares Outstanding (Basic)	2.93B	2.97B	2.98B	2.99B	2.99B	2.99B	3B	2.92B	2.86B
Shares Outstanding (Diluted)	2.93B	2.97B	2.98B	2.99B	2.99B	2.99B	3B	2.92B	2.88B
EPS (Basic)	1.48	2.16	2.07	2.28	1.96	1.40	1.08	0.80	0.64
EPS (Diluted)	1.48	2.16	2.07	2.28	1.96	1.40	1.08	0.80	0.64
EBITDA	6.96B	8.53B	7.6B	9.28B	8.09B	5.35B	5.32B	4.19B	3.25B
EBIT	5.62B	7.42B	7.61B	8.23B	7.18B	5.22B	4.5B	3.52B	2.92B
Depreciation & Amortization	1.34B	1.12B	1.07B	1.04B	906.92M	784.21M	727.46M	699.04M	568.51M